KCa3.1 (IK) modulates pancreatic cancer cell migration, invasion and proliferation: anomalous effects on TRAM-34

B Bonito1,2, D R P Sauter1,2, A Schwab3

  • 1Section for Cell Biology and Physiology, Department of Biology, University of Copenhagen, Universitetsparken 13, Copenhagen, Denmark.

Insights

Calcium-activated potassium channel 3.1 (KCa3.1) is functionally expressed in pancreatic cancer cells, driving proliferation and invasion. This study highlights KCa3.1

Area of Science:

  • Oncology
  • Molecular Biology
  • Ion Channel Physiology

Background:

  • Ion channels are increasingly recognized as key players in cancer biology.
  • Aberrant ion channel function is linked to tumor progression, affecting apoptosis, drug resistance, proliferation, and migration.
  • The calcium-activated potassium channel KCa3.1 is implicated in the progression of various cancer types.

Purpose of the Study:

  • To investigate the expression and functional role of KCa3.1 in pancreatic cancer cells.
  • To assess the implications of KCa3.1 activity on pancreatic cancer cell progression, including proliferation, migration, and invasion.

Main Methods:

  • Quantitative PCR (qPCR) to assess KCa3.1 gene expression in pancreatic cancer cell lines.
  • Patch clamp electrophysiology to characterize KCa3.1 channel activity in MiaPaCa-2 cells.
  • Pharmacological inhibition and RNA interference (RNAi) to evaluate the functional impact of KCa3.1.

Main Results:

  • KCa3.1 was abundantly expressed in pancreatic cancer cell lines.
  • Functional KCa3.1 currents were confirmed in MiaPaCa-2 cells, sensitive to known modulators and gene knockdown.
  • KCa3.1 knockdown inhibited MiaPaCa-2 cell proliferation and invasion.
  • The KCa3.1 modulator TRAM-34 showed unexpected stimulatory effects on migration and invasion, alongside increased intracellular calcium.

Conclusions:

  • Pancreatic cancer cells exhibit prominent functional expression of KCa3.1.
  • KCa3.1 plays a crucial role in pancreatic cancer cell proliferation and invasion.
  • This study is the first to identify KCa3.1's role in pancreatic ductal adenocarcinoma (PDAC) cell migration.
  • Anomalous effects of the KCa3.1 modulator TRAM-34 warrant further investigation.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K